Group items matching

in title, tags, annotations or url

Egg consumption and coronary heart disease: an epidemiologic overview. Kritchevsky SB, Kritchevsky D. J Am Coll Nutr. 2000 Oct;19(5 Suppl):549S-555S. Review. PMID: 11023006 When dietary confounders were considered, no association was seen between egg consumption at levels up to 1 + egg per day and the risk of coronary heart disease in non-diabetic men and women.

Foods rich in cocoa may improve performance on challenging mental tasks like arithmetic. This is the finding of a study presented as part of a symposium highlighting the potential of plant-based treatments presented at the British Psychological Society Annual Conference 2009 in Brighton. Crystal Haskell from the Brain, Performance and Nutrition Research Centre at Northumbria University said: "Foods containing high levels of cocoa flavanols, found in chocolate, have been shown to increase cerebral blood flow, and it has also been proven that consumption of plants that have these properties improves performance on mentally demanding tasks. We wanted to discover whether cocoa flavanols produced the same effect.

High-density lipoprotein cholesterol changes after continuous egg consumption in healthy adults. Mayurasakorn K, Srisura W, Sitphahul P, Hongto PO. J Med Assoc Thai. 2008 Mar;91(3):400-7. PMID: 18575296 CONCLUSION: In the majority of healthy adults, an addition of one egg per day to a normal fat diet could raise HDL-c levels and decreased the ratio of TC toHDL-c. Therefore, egg consumption might benefit blood cholesterol.

Biochemical effects of consumption of eggs containing omega-3 polyunsaturated fatty acids. Ohman M, Akerfeldt T, Nilsson I, Rosen C, Hansson LO, Carlsson M, Larsson A. Ups J Med Sci. 2008;113(3):315-23. PMID: 18991244 Addition of one regular egg per day to the normal diet had no negative impact on blood lipids or inflammation markers. Consumption of omega-3 enriched eggs resulted in higher levels of ApoA1, lower ApoB/ApoA1 ratio and lower plasma glucose. These effects have been associated in previous studies with a reduced risk for cardiovascular mortality and diabetes.

Egg consumption and risk of type 2 diabetes in men and women. Djoussé L, Gaziano JM, Buring JE, Lee IM. Diabetes Care. 2009 Feb;32(2):295-300. Epub 2008 Nov 18. PMID: 19017774 DOI: 10.2337/dc08-1271 CONCLUSIONS-These data suggest that high levels of egg consumption (daily) are associated with an increased risk of type 2 diabetes in men and women. Confirmation of these findings in other populations is warranted.

Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. Volvert ML, Seyen S, Piette M, Evrard B, Gangolf M, Plumier JC, Bettendorff L. BMC Pharmacol. 2008 Jun 12;8:10. PMID: 18549472 doi:10.1186/1471-2210-8-10 Conclusion Our results show that, though benfotiamine strongly increases thiamine levels in blood and liver, it has no significant effect in the brain. This would explain why beneficial effects of benfotiamine have only been observed in peripheral tissues, while sulbutiamine, a lipid-soluble thiamine disulfide derivative, that increases thiamine derivatives in the brain as well as in cultured cells, acts as a central nervous system drug. We propose that benfotiamine only penetrates the cells after dephosphorylation by intestinal alkaline phosphatases. It then enters the bloodstream as S-benzoylthiamine that is converted to thiamine in erythrocytes and in the liver. Benfotiamine, an S-acyl derivative practically insoluble in organic solvents, should therefore be differentiated from truly lipid-soluble thiamine disulfide derivatives (allithiamine and the synthetic sulbutiamine and fursultiamine) with a different mechanism of absorption and different pharmacological properties.

Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, Endo G, Kambe H. Diabetes Care. 2009 Mar;32(3):424-6. Epub 2008 Dec 15. PMID: 19074997 DOI: 10.2337/dc08-1265

A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL. J Natl Cancer Inst. 2007 Jul 18;99(14):1120-9. Epub 2007 Jul 10. PMID: 17623801

Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women.\nKremer R, Campbell PP, Reinhardt T, Gilsanz V.\nJ Clin Endocrinol Metab. 2009 Jan;94(1):67-73. Epub 2008 Nov 4.\nPMID: 18984659

An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T. Am J Clin Nutr. 2007 Sep;86(3):714-7. PMID: 17823437

In the July 2005 FASEB Journal, Adrian F. Gombart of the University of California, Los Angeles (UCLA) and his colleagues reported that vitamin D boosts production in white blood cells of one of the antimicrobial compounds that defends the body against germs.\n\nImmediately, Cannell says, the proverbial lightbulb went on in his head: Maybe the high doses of vitamin D that he had been prescribing to virtually all the men on his ward had boosted their natural arsenal of the antimicrobial, called cathelicidin, and protected them from flu. Cannell had been administering the vitamin D because his patients, like many other people in the industrial world, had shown a deficiency:

Serum 25-Hydroxyvitamin D Concentration and Cognitive Impairment.\nLlewellyn DJ, Langa K, Lang I.\nJ Geriatr Psychiatry Neurol. 2009 Feb 4. [Epub ahead of print]\nPMID: 19073839 \ndoi:10.1177/0891988708327888\n

Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. Heaney RP, Dowell MS, Hale CA, Bendich A. J Am Coll Nutr. 2003 Apr;22(2):142-6. PMID: 12672710

Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Arch Ophthalmol. 2007 May;125(5):661-9. PMID: 17502506

Not enough vitamin D: health consequences for Canadians.\nSchwalfenberg G.\nCan Fam Physician. 2007 May;53(5):841-54. Review.\nPMID: 17872747 \n

AUGUSTA, Ga. - Too little vitamin D could be bad for more than your bones; it may also lead to fatter adolescents, researchers say.\n\nA Medical College of Georgia study of more than 650 teens age 14-19 has found that those who reported higher vitamin D intakes had lower overall body fat and lower amounts of the fat in the abdomen, a type of fat known as visceral fat, which has been associated with health risks such as heart disease, stroke, diabetes and hypertension

Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P. \nVitamin D status predicts physical performance and its decline in older persons.\nJ Clin Endocrinol Metab. 2007 Jun;92(6):2058-65. Epub 2007 Mar 6.\nPMID: 17341569 [PubMed

Hathcock JN, Shao A, Vieth R, Heaney R. \nRisk assessment for vitamin D.\nAm J Clin Nutr. 2007 Jan;85(1):6-18. Review.\nPMID: 17209171 [PubMed - indexed for MEDLINE]